# OnCo record cba-1535 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cba-1535/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cba-1535" ;
  schema:name "CBA-1535"@en ;
  schema:alternateName "Tb535H"@en ;
  schema:description "CBA-1535 is an experimental trispecific T cell engager from Chiome Bioscience, in phase 1 trials for advanced solid tumours, malignant mesothelioma and small cell lung cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/cba-1535/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.chiome.co.jp/en/pipeline/>, <https://www.chiome.co.jp/en/pipeline/>, <https://clinicaltrials.gov/api/v2/studies/NCT07016997>, <https://clinicaltrials.gov/search?intr=CBA-1535> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Trispecific T cell engager (Tribody)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/chiome-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct07016997/> .